Glysantis

Business Services · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

574 Hanlon Creek Blvd, Guelph, Ontario, ...

Phone Number

(519) 829-1221

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Glysantis

Glysantis Biotech Inc. specializes in developing innovative therapies for cancer treatment, focusing on a monodisperse nanoparticle that delivers immune-activating compounds to tumors. Their technology aims to reverse immunosuppression and activate anti-tumor immunity, particularly targeting ovarian cancer patients initially. The company is led by experienced executives and seeks to enhance existing therapies for difficult-to-treat tumors. Glysantis is actively pursuing clinical trials and is open to collaborations with scientific partners and investors.Explore more
Glysantis's Social MediaPopular SearchesGlysantis IncGlysantis Animal Health IncGlysantisSIC Code 87,873NAICS Code 54,541Show more

Glysantis Org Chart

Phillip Whiting, Chief Executive Officer at Glysantis
Canada flag for contact location.

Chief Executive Officer

PhoneEmail
KL
Canada flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Glysantis your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Glysantis

Compare insights from companies similar to Glysantis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Glysantis

<$5M
11-50
Private
-
2015
$26.1M
11-50
Public
$15M
1998
Stephen Glover, Chief Operating Officer at Oncolytics Biotech
Stephen GloverChief Operating Officer
<$5M
11-50
Private
$12M
2012
CD
Cassandra DunnFounder & CEO
<$5M
11-50
Private
-
1998
WW
Wuwenyan WuVice President
<$5M
1-10
Private
-
2013
Elaine Allison, Co-Founder & Chief Executive Officer at Novelogics Biotechnology
Elaine AllisonCo-Founder & CEO
<$5M
11-50
Private
-
2004
JY
Jun YanCEO & President
<$5M
1-10
Private
-
2016
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Glysantis is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Glysantis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Glysantis.

Glysantis Tech Stack

A closer look at the technologies used by Glysantis

Top Business Services Companies

Frequently Asked Questions Regarding Glysantis

What is Glysantis's official website?
Glysantis's official website is www.glysantis.com
What is Glysantis's Revenue?
Glysantis's revenue is <$5 Million
What is Glysantis's SIC code?
Glysantis's SIC: 87,873
What is Glysantis's NAICS code?
Glysantis's NAICS: 54,541
How many employees does Glysantis have?
Glysantis has 11-50 employees
What industry does Glysantis belong to?
Glysantis is in the industry of: Business Services, Research & Development
What is Glysantis competition?
Glysantis top competitors include: Novelogics Biotechnology, SpecificiT Pharma, SignalChem Lifesciences, Lindan Biotech
What technology does Glysantis use?
Some of the popular technologies that Glysantis uses are: WooCommerce, WordPress.org, PHP, Cloudflare Website Optimization
Who is the CFO of Glysantis?
Glysantis's CFO is Kim Lyon
How do I contact Glysantis?
Glysantis contact info: Phone number: (519) 829-1221 Website: www.glysantis.com
What does Glysantis do?

Glysantis Biotech Inc. specializes in developing innovative therapies for cancer treatment, focusing on a monodisperse nanoparticle that delivers immune-activating compounds to tumors. Their technology aims to reverse immunosuppression and activate anti-tumor immunity, particularly targeting ovarian cancer patients initially. The company is led by... experienced executives and seeks to enhance existing therapies for difficult-to-treat tumors. Glysantis is actively pursuing clinical trials and is open to collaborations with scientific partners and investors.Read More

What are Glysantis social media links?
Glysantis Linkedin page
Is Glysantis a public company?
Glysantis is private company therefore does not currently have an official ticker symbol
See more information about Glysantis

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.